Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Clinical variability in DYNC2H1-related skeletal ciliopathies includes Ellis-van Creveld syndrome

Abstract

Deleterious variants of DYNC2H1 gene are associated with a wide spectrum of skeletal ciliopathies (SC). We used targeted parallel sequencing to analyze 25 molecularly unsolved families with different SCs. Deleterious DYNC2H1 variants were found in six sporadic patients and two monozygotic (MZ) twins. Clinical diagnoses included short rib-polydactyly type 3 in two cases, and asphyxiating thoracic dystrophy (ATD) in one case. Remarkably, clinical diagnosis fitted with EvC, mixed ATD/EvC and short rib-polydactyly/EvC phenotypes in three sporadic patients and the MZ twins. EvC/EvC-like features always occurred in compound heterozygotes sharing a previously unreported splice site change (c.6140-5A>G) or compound heterozygotes for two missense variants. These results expand the DYNC2H1 mutational repertoire and its clinical spectrum, suggesting that EvC may be occasionally caused by DYNC2H1 variants presumably acting as hypomorphic alleles.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: 3D structure of DYNC2H1 obtained through modeling.

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. All variants have been added to the Leiden Open Variation Database (LOVD, https://databases.lovd.nl/shared/variants/DYNC2H1/unique).

References

  1. Zhang W, Taylor SP, Ennis HA, Forlenza KN, Duran I, Li B, et al. Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies. Hum Mutat. 2018;39:152–66.

    Article  CAS  Google Scholar 

  2. Hammarsjo A, Pettersson M, Chitayat D, Handa A, Anderlid B-M, Bartocci M, et al. High diagnostic yield in skeletal ciliopathies using massively parallel genome sequencing, structural variant screening and RNA analyses. J Hum Genet. 2021;66:995–1008.

    Article  Google Scholar 

  3. Ruiz-Perez VL, Ide SE, Strom TM, Lorenz B, Wilson D, Woods K, et al. Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet. 2000;24:283–6.

    Article  CAS  Google Scholar 

  4. Ruiz-Perez VL, Tompson SW, Blair HJ, Espinoza-Valdez C, Lapunzina P, Silva E, et al. Mutations in two nonhomologous genes in a head-to-head configuration cause Ellis-van Creveld syndrome. Am J Hum Genet. 2003;72:728–32.

    Article  CAS  Google Scholar 

  5. D’Asdia MC, Torrente I, Consoli F, Ferese R, Magliozzi M, Bernardini L, et al. Novel and recurrent EVC and EVC2 mutations in Ellis-van Creveld syndrome and Weyers acrofacial dyostosis. Eur J Med Genet. 2013;56:80–87.

    Article  Google Scholar 

  6. Caparrós-Martín JA, De Luca A, Cartault F, Aglan M, Temtamy S, Otaify GA, et al. Specific variants in WDR35 cause a distinctive form of Ellis-van Creveld syndrome by disrupting the recruitment of the EvC complex and SMO into the cilium. Hum Mol Genet. 2015;24:4126–37.

    Article  Google Scholar 

  7. Niceta M, Margiotti K, Digilio MC, Guida V, Bruselles A, Pizzi S, et al. Biallelic mutations in DYNC2LI1 are a rare cause of Ellis-van Creveld syndrome. Clin Genet. 2018;93:632–9.

    Article  CAS  Google Scholar 

  8. Palencia-Campos A, Ullah A, Nevado J, Yıldırım R, Unal E, Ciorraga M, et al. GLI1 inactivation is associated with developmental phenotypes overlapping with Ellis-van Creveld syndrome. Hum Mol Genet. 2017;26:4556–71.

    Article  CAS  Google Scholar 

  9. Palencia-Campos A, Aoto PC, Machal EMF, Rivera-Barahona A, Soto-Bielicka P, Bertinetti D, et al. Germline and mosaic variants in PRKACA and PRKACB cause a multiple congenital malformation syndrome. Am J Hum Genet. 2020;107:977–88.

    Article  CAS  Google Scholar 

  10. Schmidts M, Arts HH, Bongers EM, Yap Z, Oud MM, Antony D, et al. Exome sequencing identifies DYNC2H1 mutations as a common cause of asphyxiating thoracic dystrophy (Jeune syndrome) without major polydactyly, renal or retinal involvement. J Med Genet. 2013;50:309–23.

    Article  CAS  Google Scholar 

  11. El Hokayem J, Huber C, Couve A, Baujat G, Bouvier R, Cavalcanti DP, et al. NEK1 and DYNC2H1 are both involved in short rib polydactyly Majewski type but not in Beemer Langer cases. J Med Genet. 2012;49:227–33.

    Article  CAS  Google Scholar 

  12. Wang Z, Moult J. SNPs, protein structure, and disease. Hum Mutat. 2001;17:263–70.

  13. Aubert-Mucca M, Huber C, Baujat G, Michot C, Zarhrate M, Bras M, et al. Ellis-Van Creveld Syndrome: clinical and molecular analysis of 50 individuals. J Med Genet. 2022:2022-108435.

  14. Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A .2019;179:2393–419.

    Article  Google Scholar 

  15. Ho NC, Francomano CA, van Allen M. Jeune asphyxiating thoracic dystrophy and short-rib polydactyly type III (Verma-Naumoff) are variants of the same disorder. Am J Med Genet. 2000;90:310–4.

    Article  CAS  Google Scholar 

  16. Mei L, Huang Y, Pan Q, Su W, Quan Y, Liang D, et al. Targeted next-generation sequencing identifies novel compound heterozygous mutations of DYNC2H1 in a fetus with short rib-polydactyly syndrome, type III. Case Reports. Clin Chim Acta. 2015;447:47–51.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to express our gratitude to the patients who made this study possible.

Funding

This study was supported by funding from the Italian Ministry of Health (RC‐2020 and RC-2021, to ADL; RC-2018-2021 to LM and MC; 5 × 1000, to MT and TM), and the Sapienza University of Rome research grants “avvio alla ricerca 2019 (AR11916B7A1835AC)” and “avvio alla ricerca 2021 (AR12117A86EA0740)” to FP-S.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: FP-S, BM, MT, ADL; Formal analysis: MCD, FP, LB, TM; Funding acquisition: FP-S, LM, TM, MT, MC, ADL; Investigation: FP-S, LM, BT, VG, FC, IT, AO, EF, MCD, FP, LB, CM, DC, ADL; Project administration: FP-S, ADL; Resources: FS, DG, GM, CP, FF, NB-P, AN, AP, BM, MCD, BD, VLR-P, MC; Supervision: TM, MC, ADL; Visualization: FP-S, LM, LB, MCD, TM, ADL; Writing – original draft: FP-S, LM; Writing – review & editing: TM, BD, VLR-P, MT, MC, ADL.

Corresponding author

Correspondence to Alessandro De Luca.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval

The study was performed in accordance with the principles set out in the 1984 Declaration of Helsinki and subsequent versions and was approved by the local institutional review board (no. 13/CE 2021). All patients signed an informed consent for the scientific use of clinical and genetic data. Written informed consent for publication of images was obtained.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Piceci-Sparascio, F., Micale, L., Torres, B. et al. Clinical variability in DYNC2H1-related skeletal ciliopathies includes Ellis-van Creveld syndrome. Eur J Hum Genet (2023). https://doi.org/10.1038/s41431-022-01276-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41431-022-01276-7

Search

Quick links